Search


Search Parameters








1 - 21 of 21 items
Four words regarding clinical trials: science/profit, risks/benefits Open Access
Antonio Ugalde, Núria Homedes

The sustainability of the health system and the pharmaceutical market: A permanent interaction between the cost of medications, the patent system, and disease care Open Access
Tomás Gómez Franco, Eva Matarín Rodríguez-Peral, Francisco García García

Pills for profits. The transformation of the pharmaceutical industry Open Access
Antonio Ugalde, Núria Homedes

Two more words regarding clinical trials: deception/truth, the moral anemia of Big Pharma Open Access
Marvin Gómez-Vargas

Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights Open Access
Raúl Allard Soto

Bioethical problems in researching new vaccines: Do they respond to public health reasons? Open Access
Juan Carlos Tealdi

Transformations in the management of diabetes: an analysis of the scientific evidence published by two scientific societies (1980-2010) Open Access
Mónica Serena Perner

The precautionary principle in biomedical research, safety, post-research obligations and alleged therapeutic efficacy of experimental drugs: Violations of patient dignity Open Access
Sergio Eduardo Gonorazky

Toward independent clinical trials in Latin America. Comments on "Four words regarding clinical trials" Open Access
Carlos Daniel Tajer

Clinical research in Latin America and Argentina: time for a change? Open Access
Daniel Ferrante

Questioning clinical trials Open Access
Ricardo Alberto Martínez

Clinical trials, the State and society: where does science end and profit-making begin? Open Access
Cláudio Lorenzo, Volnei Garrafa

Globalization and medical identities in clinical trials Open Access
Medardo Ávila Vázquez

Authors' response Open Access
Ugalde Antonio, Núria Homedes

The medication cycle: its impact on access to and adequate use of drugs Open Access
Homedes Núria, Ugalde Antonio

The impact of researchers loyal to Big Pharma on the ethics and quality of clinical trials in Latin America Open Access
Antonio Ugalde, Núria Homedes

The use of placebos in phase III clinical trials in Brazil Open Access
Gustavo Butzge Rubenich, Stephanie Tomasi Heck, Fernando Hellmann, Bruno Rodolfo Schlemper Junior

Commentary on the article “Bioethical problems in researching new vaccines: Do they respond to public health reasons?” Open Access
Alejandro Ellis

Scientific advances and moral progress: the end does not justify the means Open Access
Juan Carlos Tealdi

Clinical trials in Latin America: implications for the sustainability and safety of pharmaceutical markets and the wellbeing of research subjects Open Access
Núria Homedes, Antonio Ugalde

Four other keywords to critically analyze a clinical trial: hypothesis, implementation, analysis and publication Open Access
Teresa Forcades i Vila

1 - 21 of 21 items